Amsterdam, the Netherlands– Royal Philips, a global leader in health technology, today announced that, with the release of new device drivers that enable integration and interoperability ...

DUBLIN, August 24, 2017 /PRNewswire/ --The 'Global Medical Device Partnering Terms and Agreements 2010-2017: Deal trends, players and financials' ...

BALTIMORE--(BUSINESS WIRE)--Protaryx Medical, a pioneer in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study, demonstrating the ...

Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform ...

DENVER, Nov. 15, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences ...

ResMed hits the 1,000-patient milestone for apnea device study By Damian Garde May 21, 2012 9:33am Clinical Data MedTech ...

Indore (Madhya Pradesh): The Department of Atomic Energy (DAE) celebrated a significant milestone as the 5 millionth medical device was sterilised using an indigenously developed electron linear ...

Nemaura Medical NMRD is currently in the process of commercializing its sugarBEAT(R) non-invasive, flexible and affordable continuous glucose monitoring (“CGM”) device.

SeaStar Medical (ICU) has begun shipping QUELIMMUNE to a third hospital customer. QUELIMMUNE is the Company’s Selective Cytopheretic Device, SCD, for treating critically ill children in the ...